Gossamer Bio Inc. announced the closing of a $230 million Series B preferred stock financing led by Hillhouse Capital. In connection with the financing, Gossamer Bio further announced that Sheila Gujrathi, M.D., Co-Founder and current President & Chief Operating Officer, has become the Chief Executive Officer, and Co-Founder Faheem Hasnain becomes full time Executive Chairman.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.58 USD | -0.70% | -8.92% | -36.44% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.44% | 132M | |
+52.36% | 56.69B | |
-3.86% | 41B | |
+38.14% | 38.11B | |
-12.01% | 26.89B | |
+14.13% | 25.59B | |
-21.62% | 18.59B | |
+0.21% | 12.39B | |
+25.96% | 11.99B | |
+23.02% | 11.88B |
- Stock Market
- Equities
- GOSS Stock
- News Gossamer Bio, Inc.
- Gossamer Bio, Inc. Announces Executive Changes